^
+ Follow BEXTRA Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 503161
                    [Title] => Unending Pfizer woes?
                    [Summary] => 

Multinational pharmaceutical firm Pfizer is reeling under a tsunami of woes again as international media bannered last week a settlement offer it made in the face of massive lawsuits arising from its marketing of the controversial drug Bextra.

[DatePublished] => 2009-09-09 00:00:00 [ColumnID] => 134315 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) [1] => Array ( [ArticleID] => 270457 [Title] => A new drug for arthritis [Summary] => Thousands of people who have been taking the arthritis drug rofecoxib (Vioxx) are now switching to other medications. Vioxx was pulled from pharmacy shelves in September after a colon polyp prevention trial was stopped due to an increased risk of heart attack and stroke among patients randomized to take the drug. The risks emerged after 18 months during that particular trial. [DatePublished] => 2005-03-15 00:00:00 [ColumnID] => 133436 [Focus] => 0 [AuthorID] => 1778504 [AuthorName] => Tyrone M. Reyes M.D. [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
BEXTRA
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 503161
                    [Title] => Unending Pfizer woes?
                    [Summary] => 

Multinational pharmaceutical firm Pfizer is reeling under a tsunami of woes again as international media bannered last week a settlement offer it made in the face of massive lawsuits arising from its marketing of the controversial drug Bextra.

[DatePublished] => 2009-09-09 00:00:00 [ColumnID] => 134315 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) [1] => Array ( [ArticleID] => 270457 [Title] => A new drug for arthritis [Summary] => Thousands of people who have been taking the arthritis drug rofecoxib (Vioxx) are now switching to other medications. Vioxx was pulled from pharmacy shelves in September after a colon polyp prevention trial was stopped due to an increased risk of heart attack and stroke among patients randomized to take the drug. The risks emerged after 18 months during that particular trial. [DatePublished] => 2005-03-15 00:00:00 [ColumnID] => 133436 [Focus] => 0 [AuthorID] => 1778504 [AuthorName] => Tyrone M. Reyes M.D. [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with